Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:small_molecule
gptkb:drug |
| gptkbp:CASNumber |
1801787-56-3
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developer |
gptkb:H3_Biomedicine
|
| gptkbp:indication |
hepatocellular carcinoma
|
| gptkbp:intendedUse |
gptkb:cancer
|
| gptkbp:mechanismOfAction |
FGFR4 inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
H3B6527
|
| gptkbp:target |
gptkb:FGFR4
|
| gptkbp:bfsParent |
gptkb:H3_Biomedicine
|
| gptkbp:bfsLayer |
5
|
| http://www.w3.org/2000/01/rdf-schema#label |
H3B-6527
|